References
- World Health Organization. Coronavirus disease (COVID-19) situation report-127. World Health Organisation (WHO); 2020:1–17. Available from: https://apps.who.int/iris/handle/10665/332232. Accessed February 20, 2021.
- Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91:157–160. doi:10.23750/abm.v91i1.9397
- World Health Organisation. Draft landscape and tracker of COVID-19 candidate vaccines. World Health Organisation (WHO); 2020. Available from: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines. Accessed February 20, 2021.
- FDA Briefing Document. Pfizer-BioNTech COVID-19 vaccine. U.S. Food and Drug Administration; 2020:1–53. Available from: https://www.fda.gov/media/144245/download. Accessed February 11, 2021.
- FDA Briefing Document. Moderna COVID-19 Vaccine. U.S. Food and Drug Administration; 2020:1–54. Available from: https://www.fda.gov/media/144434/download. Accessed February 11, 2021.
- Centers for Disease Control and Prevention. Understanding how COVID-19 vaccines work. Vaccines. 2021. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/how-they-work.html. Accessed February 11, 2021.
- Centers for Disease Control and Prevention. What to expect at your appointment to get vaccinated for COVID-19| CDC. Vaccines. 2021. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect.html. Accessed February 11, 2021.
- Davis TC, Fredrickson DD, Arnold CL, et al. Childhood vaccine risk/benefit communication in private practice office settings: a national survey. Pediatrics. 2001;107:e17–e17. doi:10.1542/peds.107.2.e17
- Gust DA, Woodruff R, Kennedy A, Brown C, Sheedy K, Hibbs B. Parental perceptions surrounding risks and benefits of immunization. Semin Pediatr Infect Dis. 2003;14:207–212. doi:10.1016/S1045-1870(03)00035-9
- Bond L, Nolan T, Pattison P, Carlin J. Vaccine preventable diseases and immunisations: a qualitative study of mothers’ perceptions of severity, susceptibility, benefits and barriers. Aust N Z J Public Health. 1998;22:441–446. doi:10.1111/j.1467-842X.1998.tb01411.x
- MacDonald NE, Eskola J, Liang X, et al. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33:4161–4164. doi:10.1016/j.vaccine.2015.04.036
- Aranda S. Ten Threats to Global Health in 2019. World Health Organisation (WHO); 2019:1–18.
- Larson H, Cooper L, Eskola J, Katz S, Ratzan S. Addressing the vaccine confidence gap. Lancet. 2011;378(9790):526–535. doi:10.1016/S0140-6736(11)60678-8
- Wessely S. Emergency preparedness and response. J R Army Med Corps. 2018;166:jramc-2018-000965. doi:10.1136/jramc-2018-000929
- Pfizer COVID-19 vaccine EUA fact sheet for healthcare providers administering vaccine (vaccination providers). 2021:1–30. Available from: https://www.fda.gov/media/144413/download. Accessed March 31, 2021.
- Crist C. Track vaccine recipients for facial paralysis. Available from: https://www.webmd.com/vaccines/covid-19-vaccine/news/20201217/fda-says-vaccine-recipients-should-be-monitored-for-facial-paralysis. Accessed February 20, 2021.
- What we know about a link between bell’s palsy and COVID-19 vaccines. Available from: https://www.businessinsider.com/what-we-know-link-between-bells-palsy-covid-19-vaccines-2020-12. Accessed February 20, 2021.
- Polack F, Thomas S, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med. 2020;383:2603–2615. doi:10.1056/NEJMoa2034577
- Van Balveren-slingerland L, Rümke H, Kant A. Reported adverse events following influenza vaccination. Ned Tijdschr Geneeskd. 2014;158:A6841.
- Zhou W, Pool V, Iskander J, et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)–United States, 1991–2001. MMWR CDC Surveill Summ. 2003;52:1–24.